Skip to main content
. Author manuscript; available in PMC: 2018 Dec 1.
Published in final edited form as: J Surg Res. 2017 May 8;220:438–443. doi: 10.1016/j.jss.2017.04.028

Figure 3. TXA Effect on Mortality between Phenotypes in Patients Requiring Blood Product Resuscitation.

Figure 3

*=P<0.05; Hyper = hyperfibrinolysis

Figure 3 The association between fibrinolytic phenotypes and mortality contrasting the effects of tranexamic acid on patients required blood products during resuscitation is illustrated. The Y axis represents the percent mortality and X axis are fibrinolysis phenotypes. In the shutdown phenotype there were 33 patients (8 received TXA), in the physiologic phenotype there were 48 patients (8 received TXA), and in the hyperfibrinolytic phenotype there were 39 patients (10 received TXA).